%0 Journal Article
%T 肝细胞癌免疫治疗进展的研究现状与展望<br>Current Research Status and Prospects of Immunotherapy Advances in Hepatocellular Carcinoma
%A 唐铭阳
%A 张煜坤
%A 丁俊
%J Advances in Clinical Medicine
%P 254-263
%@ 2161-8720
%D 2025
%I Hans Publishing
%R 10.12677/acm.2025.151037
%X 肝细胞癌(Hepatocellular carcinoma, HCC)是原发性肝癌中最常见的类型&#65292;也是全球癌症相关死亡的主要原因之一。近年来&#65292;随着肿瘤免疫学研究的深入和免疫治疗策略的快速发展&#65292;免疫治疗在HCC治疗中展现出良好的应用前景。本文综述了HCC免疫治疗的最新研究进展&#65292;重点阐述了免疫检查点抑制剂、CAR-T细胞治疗、治疗性疫苗等免疫治疗策略在HCC中的应用现状&#65292;并对未来发展方向进行展望。<br>Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and one of the leading causes of cancer-related deaths worldwide. In recent years, with in-depth research on tumor immunology and the rapid development of immunotherapy strategies, immunotherapy has shown promising applications in the treatment of HCC. This article reviews the latest research progress in HCC immunotherapy, focuses on the current status of the application of immunotherapeutic strategies such as immune checkpoint inhibitors, CAR-T cell therapy, and therapeutic vaccines in HCC, and looks forward to the future direction of development.
%K 肝细胞癌&#65292
%K 免疫治疗&#65292
%K 免疫检查点抑制剂&#65292
%K CAR-T细胞治疗<br>Hepatocellular Carcinoma
%K Immunotherapy
%K Immune Checkpoint Inhibitors
%K Chimeric Antigen Receptor T-Cell Immunotherapy
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=104914